Literature DB >> 34073800

The Role of the Guanosine Nucleotide-Binding Protein in the Corpus Luteum.

Dody Houston Billhaq1, Seunghyung Lee1.   

Abstract

The corpus luteum is a temporary endocrine gland in the ovary. In the ovarian cycle, repeated patterns of specific cellular proliferation, differentiation, and transformation occur that accompany the formation and regression of the corpus luteum. Molecular mechanism events in the ovarian microenvironment, such as angiogenesis and apoptosis, are complex. Recently, we focused on the role of RAS protein in the ovarian corpus luteum. RAS protein plays a vital role in the modulation of cell survival, proliferation, and differentiation by molecular pathway signaling. Additionally, reproductive hormones regulate RAS activity in the cellular physiological function of ovarian follicles during pre-ovulatory maturation and ovulation. Thus, we have reviewed the role of RAS protein related to the biological events of the corpus luteum in the ovary.

Entities:  

Keywords:  RAS; corpus luteum; cows; ovary; reproduction

Year:  2021        PMID: 34073800     DOI: 10.3390/ani11061524

Source DB:  PubMed          Journal:  Animals (Basel)        ISSN: 2076-2615            Impact factor:   2.752


  74 in total

Review 1.  Mechanisms controlling the function and life span of the corpus luteum.

Authors:  G D Niswender; J L Juengel; P J Silva; M K Rollyson; E W McIntush
Journal:  Physiol Rev       Date:  2000-01       Impact factor: 37.312

Review 2.  Minireview: physiological and pathological actions of RAS in the ovary.

Authors:  Heng-Yu Fan; Joanne S Richards
Journal:  Mol Endocrinol       Date:  2009-10-30

Review 3.  Plasma membrane regulates Ras signaling networks.

Authors:  Tanmay Sanjeev Chavan; Serena Muratcioglu; Richard Marszalek; Hyunbum Jang; Ozlem Keskin; Attila Gursoy; Ruth Nussinov; Vadim Gaponenko
Journal:  Cell Logist       Date:  2016-02-18

Review 4.  The ovary: basic biology and clinical implications.

Authors:  Joanne S Richards; Stephanie A Pangas
Journal:  J Clin Invest       Date:  2010-04-01       Impact factor: 14.808

5.  The efficacy of IGF-I receptor monoclonal antibody against human gastrointestinal carcinomas is independent of k-ras mutation status.

Authors:  Masanori Ii; Hua Li; Yasushi Adachi; Hiroyuki Yamamoto; Hirokazu Ohashi; Hiroaki Taniguchi; Yoshiaki Arimura; David P Carbone; Kohzoh Imai; Yasuhisa Shinomura
Journal:  Clin Cancer Res       Date:  2011-06-03       Impact factor: 12.531

Review 6.  Impact of follicle stimulating hormone receptor variants in fertility.

Authors:  Maria D Lalioti
Journal:  Curr Opin Obstet Gynecol       Date:  2011-06       Impact factor: 1.927

Review 7.  RAS oncogenes: weaving a tumorigenic web.

Authors:  Yuliya Pylayeva-Gupta; Elda Grabocka; Dafna Bar-Sagi
Journal:  Nat Rev Cancer       Date:  2011-10-13       Impact factor: 60.716

Review 8.  RAS proto-oncogene in medullary thyroid carcinoma.

Authors:  Margarida M Moura; Branca M Cavaco; Valeriano Leite
Journal:  Endocr Relat Cancer       Date:  2015-10       Impact factor: 5.678

9.  PKA and GAB2 play central roles in the FSH signaling pathway to PI3K and AKT in ovarian granulosa cells.

Authors:  Mary E Hunzicker-Dunn; Blanca Lopez-Biladeau; Nathan C Law; Sarah E Fiedler; Daniel W Carr; Evelyn T Maizels
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

Review 10.  The hypothalamic GnRH pulse generator: multiple regulatory mechanisms.

Authors:  Lazar Z Krsmanovic; Lian Hu; Po-Ki Leung; Hao Feng; Kevin J Catt
Journal:  Trends Endocrinol Metab       Date:  2009-09-07       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.